Concord Medical Files 2021 Annual Report on Form 20-F

Rhea-AI Summary

Concord Medical Services Holdings Limited (NYSE: CCM) announced the filing of its annual report on Form 20-F for the fiscal year ending December 31, 2021, with the U.S. Securities and Exchange Commission. The annual report is available electronically on Concord Medical's investor relations website and the SEC's website. The company is dedicated to providing premium oncology services, including diagnosis, treatment, and prevention through its network of cancer hospitals in China, emphasizing technological advancements like the proton therapy system.

Positive

• Filed annual report on Form 20-F for FY 2021, ensuring compliance with SEC regulations.
• Continues to enhance its oncology services, emphasizing advanced treatment technologies.

Negative

• None.

BEIJING, April 29, 2022 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a healthcare provider specialized in cancer treatment, research, education and prevention by establishing proton centers, premium cancer hospitals, and specialty cancer hospitals and operating an extensive network of radiotherapy and diagnostic imaging centers in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 (the "Annual Report") with the U.S. Securities and Exchange Commission. An electronic copy of the Annual Report can be accessed on Concord Medical's investor relations website at http://ir.ccm.cn and on the SEC's website at www.sec.gov. Shareholders may receive a hard copy of the Annual Report free of charge upon request. Requests should be submitted to http://ir.ccm.cn.

About Concord Medical

Concord Medical Services Holdings Limited (NYSE: CCM) is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care approach in all areas of oncology services in its cancer hospitals and equipping its hospitals with technologically advanced equipment such as the state-of-the-art proton therapy system. Collaborating with domestic and international leading intelligence, we are striving to improve the quality and accessibility of cancer care. Our network of medically advanced cancer hospitals and clinics and partnered hospitals across China ensures the commitment to the highest standard of medical services for patients. Because, be the patients' most trusted anti-cancer partner is our vision. For more information, please see http://ir.ccm.cn.

 

 

View original content:https://www.prnewswire.com/news-releases/concord-medical-files-2021-annual-report-on-form-20-f-301536673.html

SOURCE Concord Medical Services Holdings Limited

FAQ

What is Concord Medical's latest annual report date?

Concord Medical filed its annual report on April 29, 2022, for the fiscal year ending December 31, 2021.

Where can I access Concord Medical's annual report?

The annual report can be accessed on Concord Medical's investor relations website and the SEC's website.

What is Concord Medical's stock symbol?

Concord Medical's stock symbol is CCM.

What services does Concord Medical provide?

Concord Medical specializes in a full cycle of oncology services including cancer diagnosis, treatment, education, and prevention.